Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock.
Open Access
- 1 January 1989
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 83 (1) , 243-251
- https://doi.org/10.1172/jci113866
Abstract
Using different types of bacteria and a canine model simulating human septic shock, we investigated the role of endotoxin in cardiovascular dysfunction and mortality. Either Escherichia coli (a microorganism with endotoxin) or Staphylococcus aureus (a microorganism without endotoxin) were placed in an intraperitoneal clot in doses of viable or formalin-killed bacteria. Cardiovascular function of conscious animals was studied using simultaneous radionuclide heart scans and thermodilution cardiac outputs. Serial plasma endotoxin levels were measured. S. aureus produced a pattern of reversible cardiovascular dysfunction over 7-10 d that was concordant (P less than 0.01) with that of E. coli. Although this cardiovascular pattern was not altered by formalin killing (S. aureus and E. coli), formalin-killed organisms produced a lower mortality and less myocardial depression (P less than 0.01). S. aureus, compared to E. coli, produced higher postmortem concentrations of microorganisms and higher mortality (P less than 0.025). E. coli produced significant endotoxemia (P less than 0.01), though viable organisms (versus nonviable) resulted in higher endotoxin blood concentrations (P less than 0.05). Significant endotoxemia did not occur with S. aureus. Thus, in the absence of endotoxemia, S. aureus induced the same cardiovascular abnormalities of septic shock as E. coli. These findings indicate that structurally and functionally distinct microorganisms, with or without endotoxin, can activate a common pathway resulting in similar cardiovascular injury and mortality.Keywords
This publication has 26 references indexed in Scilit:
- Serial cardiovascular variables in survivors and nonsurvivors of human septic shockCritical Care Medicine, 1987
- Clinical and Bacteriologic Observations of a Toxic Shock–like Syndrome Due toStreptococcus pyogenesNew England Journal of Medicine, 1987
- Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock.Journal of Clinical Investigation, 1986
- A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.Journal of Clinical Investigation, 1985
- The systemic septic responseCritical Care Medicine, 1980
- Cardiopulmonary Effects of Volume Loading in Patients in Septic ShockAnnals of Surgery, 1977
- POSSIBLE PATHOGENIC ROLE OF ENDOTOXIN IN REYE'S SYNDROMEThe Lancet, 1975
- Circulating Factors in the Etiology of Pulmonary Insufficiency and Right Heart Failure Accompanying Severe Sepsis (Peritonitis)Annals of Surgery, 1970
- Abnormal Vascular Tone, Defective Oxygen Transport And Myocardial Failure In Human Septic ShockAnnals of Surgery, 1967
- ON THE ABSORPTION OF BACTERIAL ENDOTOXIN FROM THE GASTRO-INTESTINAL TRACT OF THE NORMAL AND SHOCKED ANIMALThe Journal of Experimental Medicine, 1960